Does the media refer more to ARDT or CAI?

In the previous week, Caris Life Sciences had 1 more articles in the media than Ardent Health. MarketBeat recorded 2 mentions for Caris Life Sciences and 1 mentions for Ardent Health. Caris Life Sciences' average media sentiment score of 1.42 beat Ardent Health's score of 1.01 indicating that Caris Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Caris Life Sciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, ARDT or BLLN?

Ardent Health has higher revenue and earnings than Billiontoone. Ardent Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ardent Health $6.43B 0.21 $135.81M $0.95 9.83 Billiontoone $354.54M 14.56 $7.45M $0.55 204.07

Does the media refer more to ARDT or BLLN?

In the previous week, Billiontoone had 2 more articles in the media than Ardent Health. MarketBeat recorded 3 mentions for Billiontoone and 1 mentions for Ardent Health. Ardent Health's average media sentiment score of 1.01 beat Billiontoone's score of 0.96 indicating that Ardent Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, ARDT or RDNT?

Ardent Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ardent Health $6.43B 0.21 $135.81M $0.95 9.83 RadNet $2.04B 2.31 -$18.65M -$0.18 N/A

Is ARDT or RDNT more profitable?

Ardent Health has a net margin of 2.09% compared to RadNet's net margin of -0.66%. Ardent Health's return on equity of 13.85% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets Ardent Health 2.09% 13.85% 4.48% RadNet -0.66% 2.77% 0.97%

Does the media favor ARDT or RDNT?

In the previous week, RadNet had 10 more articles in the media than Ardent Health. MarketBeat recorded 11 mentions for RadNet and 1 mentions for Ardent Health. Ardent Health's average media sentiment score of 1.01 beat RadNet's score of 0.21 indicating that Ardent Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to CELC or ARDT?

In the previous week, Celcuity had 1 more articles in the media than Ardent Health. MarketBeat recorded 2 mentions for Celcuity and 1 mentions for Ardent Health. Ardent Health's average media sentiment score of 1.01 beat Celcuity's score of 0.93 indicating that Ardent Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ardent Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Ardent Health (ARDT) Competitors

$9.34 -0.06 (-0.67%)

Closing price 06/25/2026 03:59 PM Eastern

Extended Trading

$9.36 +0.02 (+0.25%)

As of 05:47 AM Eastern

Compare

ARDT vs. CAI, BLLN, SHC, RDNT, and CELC

Should you buy Ardent Health stock or one of its competitors? MarketBeat compares Ardent Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ardent Health include Caris Life Sciences (CAI), Billiontoone (BLLN), Sotera Health (SHC), RadNet (RDNT), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

How does Ardent Health compare to Caris Life Sciences?

Ardent Health (NYSE:ARDT) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.

Ardent Health has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardent Health	$6.43B	0.21	$135.81M	$0.95	9.83
Caris Life Sciences	$348.89M	15.15	-$68.09M	-$7.61	N/A

In the previous week, Caris Life Sciences had 1 more articles in the media than Ardent Health. MarketBeat recorded 2 mentions for Caris Life Sciences and 1 mentions for Ardent Health. Caris Life Sciences' average media sentiment score of 1.42 beat Ardent Health's score of 1.01 indicating that Caris Life Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ardent Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Caris Life Sciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Caris Life Sciences has a net margin of 3.75% compared to Ardent Health's net margin of 2.09%. Caris Life Sciences' return on equity of 98.28% beat Ardent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ardent Health	2.09%	13.85%	4.48%
Caris Life Sciences	3.75%	98.28%	48.87%

Ardent Health presently has a consensus target price of $14.21, suggesting a potential upside of 52.17%. Caris Life Sciences has a consensus target price of $27.56, suggesting a potential upside of 47.36%. Given Ardent Health's higher possible upside, equities research analysts plainly believe Ardent Health is more favorable than Caris Life Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

Summary

Caris Life Sciences beats Ardent Health on 7 of the 13 factors compared between the two stocks.

How does Ardent Health compare to Billiontoone?

Ardent Health (NYSE:ARDT) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

In the previous week, Billiontoone had 2 more articles in the media than Ardent Health. MarketBeat recorded 3 mentions for Billiontoone and 1 mentions for Ardent Health. Ardent Health's average media sentiment score of 1.01 beat Billiontoone's score of 0.96 indicating that Ardent Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ardent Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Ardent Health currently has a consensus target price of $14.21, suggesting a potential upside of 52.17%. Billiontoone has a consensus target price of $125.29, suggesting a potential upside of 11.62%. Given Ardent Health's higher probable upside, research analysts clearly believe Ardent Health is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Ardent Health has higher revenue and earnings than Billiontoone. Ardent Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardent Health	$6.43B	0.21	$135.81M	$0.95	9.83
Billiontoone	$354.54M	14.56	$7.45M	$0.55	204.07

Ardent Health has a net margin of 2.09% compared to Billiontoone's net margin of 0.00%. Ardent Health's return on equity of 13.85% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ardent Health	2.09%	13.85%	4.48%
Billiontoone	N/A	N/A	N/A

Summary

Ardent Health beats Billiontoone on 9 of the 13 factors compared between the two stocks.

How does Ardent Health compare to Sotera Health?

Ardent Health (NYSE:ARDT) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

Ardent Health has higher revenue and earnings than Sotera Health. Ardent Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardent Health	$6.43B	0.21	$135.81M	$0.95	9.83
Sotera Health	$1.16B	4.19	$77.94M	$0.41	41.71

Sotera Health has a net margin of 9.91% compared to Ardent Health's net margin of 2.09%. Sotera Health's return on equity of 39.73% beat Ardent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ardent Health	2.09%	13.85%	4.48%
Sotera Health	9.91%	39.73%	7.05%

91.0% of Sotera Health shares are owned by institutional investors. 1.9% of Ardent Health shares are owned by company insiders. Comparatively, 15.4% of Sotera Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Ardent Health presently has a consensus price target of $14.21, suggesting a potential upside of 52.17%. Sotera Health has a consensus price target of $20.25, suggesting a potential upside of 18.42%. Given Ardent Health's higher probable upside, research analysts clearly believe Ardent Health is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Ardent Health has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market. Comparatively, Sotera Health has a beta of 1.79, indicating that its stock price is 79% more volatile than the broader market.

In the previous week, Ardent Health and Ardent Health both had 1 articles in the media. Sotera Health's average media sentiment score of 1.87 beat Ardent Health's score of 1.01 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Ardent Health	Positive
Sotera Health	Very Positive

Summary

Sotera Health beats Ardent Health on 11 of the 15 factors compared between the two stocks.

How does Ardent Health compare to RadNet?

Ardent Health (NYSE:ARDT) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

77.9% of RadNet shares are owned by institutional investors. 1.9% of Ardent Health shares are owned by insiders. Comparatively, 5.6% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Ardent Health has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market. Comparatively, RadNet has a beta of 1.41, suggesting that its share price is 41% more volatile than the broader market.

Ardent Health has a net margin of 2.09% compared to RadNet's net margin of -0.66%. Ardent Health's return on equity of 13.85% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ardent Health	2.09%	13.85%	4.48%
RadNet	-0.66%	2.77%	0.97%

Ardent Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardent Health	$6.43B	0.21	$135.81M	$0.95	9.83
RadNet	$2.04B	2.31	-$18.65M	-$0.18	N/A

Ardent Health presently has a consensus target price of $14.21, indicating a potential upside of 52.17%. RadNet has a consensus target price of $87.43, indicating a potential upside of 45.69%. Given Ardent Health's higher probable upside, research analysts plainly believe Ardent Health is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

In the previous week, RadNet had 10 more articles in the media than Ardent Health. MarketBeat recorded 11 mentions for RadNet and 1 mentions for Ardent Health. Ardent Health's average media sentiment score of 1.01 beat RadNet's score of 0.21 indicating that Ardent Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ardent Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Ardent Health beats RadNet on 10 of the 17 factors compared between the two stocks.

How does Ardent Health compare to Celcuity?

Celcuity (NASDAQ:CELC) and Ardent Health (NYSE:ARDT) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

Ardent Health has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Ardent Health	$6.43B	0.21	$135.81M	$0.95	9.83

Celcuity presently has a consensus target price of $152.09, indicating a potential upside of 58.54%. Ardent Health has a consensus target price of $14.21, indicating a potential upside of 52.17%. Given Celcuity's stronger consensus rating and higher possible upside, equities research analysts clearly believe Celcuity is more favorable than Ardent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

In the previous week, Celcuity had 1 more articles in the media than Ardent Health. MarketBeat recorded 2 mentions for Celcuity and 1 mentions for Ardent Health. Ardent Health's average media sentiment score of 1.01 beat Celcuity's score of 0.93 indicating that Ardent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ardent Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

63.3% of Celcuity shares are held by institutional investors. 13.3% of Celcuity shares are held by company insiders. Comparatively, 1.9% of Ardent Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Ardent Health has a net margin of 2.09% compared to Celcuity's net margin of 0.00%. Ardent Health's return on equity of 13.85% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Ardent Health	2.09%	13.85%	4.48%

Celcuity has a beta of 0.1, suggesting that its stock price is 90% less volatile than the broader market. Comparatively, Ardent Health has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market.

Summary

Ardent Health beats Celcuity on 9 of the 15 factors compared between the two stocks.

Get Ardent Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ARDT vs. The Competition

Export

Metric	Ardent Health	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$1.35B	$9.11B	$6.61B	$23.14B
Dividend Yield	N/A	1.71%	2.67%	4.06%
P/E Ratio	9.83	25.50	25.76	31.50
Price / Sales	0.21	16.83	553.28	20.78
Price / Cash	3.42	106.49	46.33	24.53
Price / Book	0.79	5.92	10.70	4.69
Net Income	$135.81M	$177.22M	$3.57B	$1.07B
7 Day Performance	4.64%	2.32%	0.79%	-0.15%
1 Month Performance	0.29%	4.70%	0.22%	-0.18%
1 Year Performance	-29.77%	11.85%	30.84%	23.79%

Ardent Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ARDT Ardent Health	4.2711 of 5 stars	$9.34 -0.7%	$14.21 +52.2%	-28.9%	$1.35B	$6.43B	9.83	25,200	Positive News
CAI Caris Life Sciences	4.2121 of 5 stars	$18.27 +0.5%	$27.56 +50.9%	N/A	$5.15B	$812.03M	N/A	1,846	Positive News
BLLN Billiontoone	3.491 of 5 stars	$100.42 -3.4%	$125.29 +24.8%	N/A	$4.62B	$305.11M	182.61	620	Analyst Upgrade
SHC Sotera Health	4.1293 of 5 stars	$16.14 -0.6%	$20.29 +25.7%	+53.5%	$4.60B	$1.16B	39.33	3,000	Analyst Forecast
RDNT RadNet	3.3838 of 5 stars	$58.19 +2.0%	$87.43 +50.2%	+7.0%	$4.55B	$2.04B	N/A	11,264	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ARDT) was last updated on 6/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ardent Health (ARDT) Competitors

ARDT vs. CAI, BLLN, SHC, RDNT, and CELC

How does Ardent Health compare to Caris Life Sciences?

Summary

How does Ardent Health compare to Billiontoone?

Summary

How does Ardent Health compare to Sotera Health?

Summary

How does Ardent Health compare to RadNet?

Summary

How does Ardent Health compare to Celcuity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARDT vs. The Competition

Ardent Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ardent Health (ARDT) Competitors

ARDT vs. CAI, BLLN, SHC, RDNT, and CELC

How does Ardent Health compare to Caris Life Sciences?

Which has preferable earnings & valuation, ARDT or CAI?

Does the media refer more to ARDT or CAI?

Is ARDT or CAI more profitable?

Do analysts recommend ARDT or CAI?

Summary

How does Ardent Health compare to Billiontoone?

Does the media refer more to ARDT or BLLN?

Do analysts recommend ARDT or BLLN?

Which has stronger valuation & earnings, ARDT or BLLN?

Is ARDT or BLLN more profitable?

Summary

How does Ardent Health compare to Sotera Health?

Which has stronger earnings & valuation, ARDT or SHC?

Is ARDT or SHC more profitable?

Do institutionals & insiders hold more shares of ARDT or SHC?

Do analysts rate ARDT or SHC?

Which has more risk and volatility, ARDT or SHC?

Does the media refer more to ARDT or SHC?

Summary

How does Ardent Health compare to RadNet?

Do institutionals and insiders believe in ARDT or RDNT?

Which has more risk and volatility, ARDT or RDNT?

Is ARDT or RDNT more profitable?

Which has better valuation & earnings, ARDT or RDNT?

Do analysts prefer ARDT or RDNT?

Does the media favor ARDT or RDNT?

Summary

How does Ardent Health compare to Celcuity?

Which has stronger earnings and valuation, CELC or ARDT?

Do analysts recommend CELC or ARDT?

Does the media refer more to CELC or ARDT?

Do insiders & institutionals have more ownership in CELC or ARDT?

Is CELC or ARDT more profitable?

Which has more volatility and risk, CELC or ARDT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARDT vs. The Competition

Ardent Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools